Talasaz AmirAli
Guardant Health Inc · Co-Chief Executive Officer
Talasaz AmirAli is listed in public filings as director, officer: Co-Chief Executive Officer. This Talasaz AmirAli insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Guardant Health Inc (GH). Investors use Talasaz AmirAli's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $214M1.9M shares | SellMay 20, 2026 | $4.2M37.9k shares | $112.02 | -- | |
| $217M2M shares | SellMay 20, 2026 | $4.1M37.2k shares | $111.14 | -- | |
| $219M2M shares | SellMay 20, 2026 | $3.6M33.1k shares | $108.11 | -- | |
| $219M2M shares | SellMay 20, 2026 | $3.2M28.9k shares | $110.10 | -- | |
| $213M1.9M shares | SellMay 20, 2026 | $3.0M26.4k shares | $112.76 | -- | |
| $220M2.1M shares | SellMay 20, 2026 | $2.3M21.2k shares | $106.99 | -- | |
| $219M2.1M shares | SellMay 20, 2026 | $1.3M11.9k shares | $105.01 | -- | |
| $220M2M shares | SellMay 20, 2026 | $1.1M9.9k shares | $108.97 | -- | |
| $217M2.1M shares | SellMay 20, 2026 | $141.8K1.4k shares | $103.82 | -- | |
| $220M2.1M shares | SellMay 20, 2026 | $127.0K1.2k shares | $105.88 | -- | |
| $215M2.1M shares | SellMay 20, 2026 | $92.3K900 shares | $102.57 | -- | |
| $212M2.1M shares | SellMay 20, 2026 | $20.2K200 shares | $100.95 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $210M2.1M shares | SellMay 12, 2026 | $5.0M50k shares | $100.32 | -- | |
| $196M2.1M shares | Grant / ExerciseApr 1, 2026 | $1.6M17.1k shares | $91.15 | -- | |
| --68k shares | Grant / ExerciseApr 1, 2026 | Disclosure amount unavailable9.7k shares | -- | -- | |
| --72k shares | Grant / ExerciseApr 1, 2026 | Disclosure amount unavailable24k shares | -- | -- | |
| --8.5k shares | Grant / ExerciseMar 31, 2026 | Disclosure amount unavailable2.8k shares | -- | -- | |
| $197M2.1M shares | Grant / ExerciseMar 31, 2026 | $131.9K1.4k shares | $92.37 | -- | |
| --11.3k shares | Grant / ExerciseMar 17, 2026 | Disclosure amount unavailable11.3k shares | -- | -- | |
| --101.4k shares | Grant / ExerciseMar 17, 2026 | Disclosure amount unavailable101.4k shares | -- | -- | |
| $182M2.1M shares | Grant / ExerciseMar 13, 2026 | $1.2M13.7k shares | $85.49 | -- | |
| --27k shares | Grant / ExerciseMar 13, 2026 | Disclosure amount unavailable27k shares | -- | -- | |
| $216M2.1M shares | Grant / ExerciseJan 1, 2026 | $2.0M19.4k shares | $102.14 | -- | |
| --13.2k shares | OtherJan 1, 2026 | Disclosure amount unavailable13.2k shares | -- | -- | |
| --77.7k shares | Grant / ExerciseJan 1, 2026 | Disclosure amount unavailable38.3k shares | -- | -- |